Berkshire Health Systems Taps New Chief Medical Officer/Chief Quality Officer

PITTSFIELD, Mass. — Dr. James Weil Lederer Jr. has been appointed to the position of chief medical officer/chief quality officer at Berkshire Health Systems.

"Dr. Lederer has over 20 years of experience in leading innovative, patient-focused, high-quality care initiatives in settings spanning acute-care hospitals, health systems and physician practices," said David Phelps, BHS president and chief executive officer. "He has shown to be a proven leader and will help our team to further advance the patient safety and quality initiatives that have placed us among the national leaders in patient care."

Lederer most recently served as the vice president for Clinical Excellence of Allspire Health Partners in Conshohocken, Pa., where he was responsible for setting clinical priorities and establishing best practices for member organizations. Prior to that, he was the CMO/CQO and vice president for Quality and Safety at Saint Alphonsus Health System in Boise, Idaho, where he coordinated all clinical and safety efforts, including graduate medical education, population health, clinical improvement activities and physician leadership programs.

Lederer's previous senior leadership roles were at Novant Health in Winston Salem, N.C., including vice president of Clinical Improvement, medical director of Novant Health Corporate, and senior vice president for medical affairs at Novant's Forsyth Medical Center.

Lederer is board-certified in internal medicine and adult infectious diseases. He received his medical degree from the University of North Carolina School of Medicine in Chapel Hill and completed his residency in combined medicine/pediatrics at the University of Tennessee, as well as a fellowship in infectious diseases at St. Jude Children's Research Hospital in Memphis, Tenn.

Dalton Board Signs Off on Land Sale Over Residents' Objections

By Sabrina DammsiBerkshires Staff
05:50AM / Tuesday, December 23, 2025

Residents demanded the right to speak but the agenda did not include public comment. Amy Musante holds a sign saying the town now as '$20,000 less for a police station.'

DALTON, Mass. — The Select Board signed the sale on the last of what had been known as the Bardin property Monday even as a handful of residents demanded the right to speak against the action. 

 

The quitclaim deed transfers the nine acres to Thomas and Esther Balardini, who purchased the two other parcels in Dalton. They were the third-highest bidders at $31,500. Despite this, the board awarded them the land in an effort to keep the property intact.

 

"It's going to be an ongoing battle but one I think that has to be fought [because of] the disregard for the taxpayers," said Dicken Crane, the high bidder at $51,510.

 

"If it was personal I would let it go, but this affects everyone and backing down is not in my nature." 

 

Crane had appealed to the board to accept his bid during two previous meetings. He and others opposed to accepting the lower bid say it cost the town $20,000. After the meeting, Crane said he will be filing a lawsuit and has a citizen's petition for the next town meeting with over 100 signatures. 

 

Three members of the board — Chair Robert Bishop Jr., John Boyle, and Marc Strout — attended the 10-minute meeting. Members Anthony Pagliarulo and Daniel Esko previously expressed their disapproval of the sale to the Balardinis. 

 

Pagliarulo voted against the sale but did sign the purchase-and-sale agreement earlier this month. His reasoning was the explanation by the town attorney during an executive session that, unlike procurement, where the board is required to accept the lowest bid for services, it does have some discretion when it comes to accepting bids in this instance.